Pere Domingo Selected Research

Stavudine (Zerit)

1/2014	Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study.
6/2013	Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS.
1/2013	Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy.
1/2013	Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients.
5/2012	Drug safety evaluation profile of stavudine plus lamivudine for HIV-1/AIDS infection.
4/2010	Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.
7/2004	Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pere Domingo Research Topics

Disease

51	Infections 07/2022 - 09/2003
42	Lipodystrophy 01/2022 - 08/2002
31	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 04/2003
30	HIV Infections (HIV Infection) 05/2020 - 03/2002
20	Inflammation (Inflammations) 12/2022 - 03/2008
16	Insulin Resistance 01/2022 - 10/2003
13	COVID-19 12/2022 - 01/2021
9	Obesity 01/2020 - 09/2009
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2007
7	Disease Progression 01/2022 - 04/2003
7	Liver Cirrhosis (Hepatic Cirrhosis) 10/2018 - 01/2007
6	Dyslipidemias (Dyslipidemia) 01/2022 - 07/2004
6	Fibrosis (Cirrhosis) 01/2022 - 02/2012
6	Coinfection 10/2021 - 01/2007
6	Exanthema (Rash) 10/2018 - 10/2004
4	Neoplasms (Cancer) 01/2022 - 11/2010
4	Hypertension (High Blood Pressure) 10/2021 - 01/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 03/2015
4	Osteoporosis 05/2018 - 12/2014
4	Lipomatosis 01/2015 - 04/2004
4	Chronic Renal Insufficiency 01/2015 - 01/2014
4	Necrosis 01/2012 - 01/2006
3	Meningitis 11/2020 - 01/2002
3	Hypertriglyceridemia 01/2018 - 04/2004
3	Metabolic Bone Diseases (Osteopenia) 01/2017 - 12/2014
3	Opportunistic Infections (Opportunistic Infection) 10/2016 - 05/2012
3	Hepatitis C 04/2014 - 11/2004
3	Hypercholesterolemia 07/2013 - 04/2004
3	Hypertrophy 01/2013 - 08/2007
3	Tuberculosis (Tuberculoses) 01/2011 - 11/2005
3	Viremia 04/2010 - 09/2005
2	Pneumonia (Pneumonitis) 12/2022 - 08/2009
2	Weight Gain 12/2021 - 01/2020
2	Meningococcal Infections 01/2019 - 01/2002
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2017
2	Drug-Related Side Effects and Adverse Reactions 01/2017 - 10/2014

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 06/2021 - 06/2002
15	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2003
12	LipidsIBA 12/2022 - 09/2003
10	NucleosidesIBA 01/2020 - 03/2002
10	Protease Inhibitors (Protease Inhibitor)IBA 09/2019 - 09/2003
10	Ritonavir (Norvir)FDA Link 01/2017 - 11/2005
9	CytokinesIBA 01/2022 - 12/2004
9	Reverse Transcriptase InhibitorsIBA 01/2020 - 03/2002
9	abacavir (Ziagen)FDA Link 12/2016 - 06/2002
9	efavirenz (Sustiva)FDA Link 02/2012 - 02/2002
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 11/2006
8	Triglycerides (Triacylglycerol)IBA 01/2018 - 10/2003
7	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2015
7	Tenofovir (Viread)FDA Link 01/2022 - 07/2004
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2007
7	Lopinavir FDA Link 07/2015 - 01/2007
7	Stavudine (Zerit)FDA LinkGeneric 01/2014 - 07/2004
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2009
6	Interleukin-6 (Interleukin 6)IBA 10/2021 - 04/2008
6	fibroblast growth factor 21IBA 10/2018 - 11/2010
6	Lamivudine (Epivir)FDA Link 07/2015 - 11/2005
6	AdipokinesIBA 03/2013 - 01/2006
5	Raltegravir Potassium FDA Link 01/2014 - 11/2009
4	C-Reactive ProteinIBA 01/2022 - 01/2015
4	AdiponectinIBA 12/2021 - 01/2006
4	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 11/2010
4	dolutegravirIBA 11/2020 - 11/2013
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 01/2010
4	Mitochondrial DNA (mtDNA)IBA 08/2014 - 07/2004
4	Insulin (Novolin)FDA Link 12/2012 - 01/2007
3	RacivirIBA 01/2022 - 01/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 10/2018
3	Integrase InhibitorsIBA 01/2020 - 03/2015
3	ThymidineIBA 01/2020 - 07/2009
3	lamivudine drug combination abacavir FDA Link 01/2017 - 04/2006
3	Interleukin-18 (Interleukin 18)IBA 10/2013 - 05/2012
3	stavudine triphosphateIBA 01/2013 - 04/2010
3	HDL CholesterolIBA 12/2012 - 01/2007
3	PPAR gammaIBA 10/2012 - 11/2006
3	Zidovudine (Retrovir)FDA LinkGeneric 01/2012 - 10/2008
3	Nevirapine (Viramune)FDA Link 08/2011 - 09/2003
3	Didanosine (Videx)FDA LinkGeneric 01/2009 - 11/2005
3	Rifampin (Rifampicin)FDA LinkGeneric 04/2007 - 10/2004
2	Emtricitabine (Emtriva)FDA Link 01/2022 - 07/2015
2	Hepatitis C AntibodiesIBA 01/2022 - 03/2016
2	VaccinesIBA 01/2022 - 07/2005
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 06/2015
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 07/2015
2	Immunologic Factors (Immunomodulators)IBA 11/2021 - 10/2021
2	fibrin fragment D (D-dimer)IBA 10/2021 - 06/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021 - 12/2004
2	Rilpivirine (TMC-278)IBA 01/2020 - 06/2012
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2020 - 01/2010
2	Darunavir (Prezista)FDA Link 01/2020 - 02/2011
2	InterferonsIBA 10/2018 - 04/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 01/2007

Therapy/Procedure

65	Therapeutics 12/2022 - 01/2002
46	Highly Active Antiretroviral Therapy (HAART) 05/2022 - 08/2002
2	Aftercare (After-Treatment) 12/2022 - 01/2007
2	Length of Stay 12/2022 - 07/2022
2	Artificial Respiration (Mechanical Ventilation) 10/2021 - 07/2021
2	Art Therapy 05/2018 - 01/2018
2	Salvage Therapy 01/2017 - 02/2011